Replies to post #185 on Enzon Pharmaceuticals Inc. (ENZN)

[jgusciora]

That wasn't my point of the post. Look at who sits on the board. One of Icahn's managing directors. This isn't about long term life of a company. It is about a company with a shelf life that has little overhead costs and strong revenues for the next 2-3 years. Those revenues will be returned to shareholders in the form of special dividends. They have enough cash now to do a 50% dividend and let the cash stack up to do another at years end.